Show Summary Details
Page of

Epidemiology and intervention 

Epidemiology and intervention
Epidemiology and intervention

Dr Hasan Jilaihawi

, Dr Natalia Briceno

, Dr Joerg Seeburger

, and Friedrich Mohr

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 January 2021

Within this chapter we have tried to include those papers which have, by themselves, provoked a shift in our understanding of PAH (and one relating to CTEPH) and have moved the field forward. Many of the developments in our understanding have come from work in cardiovascular biology and risen to prominence in piecemeal fashion. As is always the case with research, the uncertainty of experimentation means that many studies in PAH do not stand alone. They are reliant on previous trials or lacked power to show a conclusive result. This has been a continuing problem in PAH trials as ethical considerations restrict the use of mortality end points and the number of cases remain relatively small. However, we have been able to select the most worthy papers in pulmonary hypertension; they demonstrate the ingenuity and originality of the researchers, feature coherent scientific arguments firmly supported by appropriate data, and still stand up as examples of how to conduct research in a rare, but important disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.